One has to wonder who checks the costing that Novartis uses to justify the price of its Kymriah Cancer Drug. What would Robert Koch, Louis Pasteur or Alexander Fleming make of this behaviour?
https://www.bloomberg.com//news/articles/2017-08-30/cancer-breakthrough-heralds-new-era-of-cures-costs-and-choices
Cook Political Reports Democrats Lead Senate Races in Ohio, Texas, and Iowa
-
We are nearing the "stick a fork in it" stage.
12 hours ago
No comments:
Post a Comment